Bhatia V, Vikram V, Chandel A, Rattan A
Inflammopharmacology. 2025; .
PMID: 40088370
DOI: 10.1007/s10787-025-01715-z.
Thal D, Poesen K, Vandenberghe R, De Meyer S
Mol Neurodegener. 2025; 20(1):33.
PMID: 40087672
DOI: 10.1186/s13024-025-00819-y.
Nadais A, Martins I, Henriques A, Trigo D, da Cruz E Silva O
Cell Mol Neurobiol. 2025; 45(1):24.
PMID: 40080205
PMC: 11906958.
DOI: 10.1007/s10571-025-01539-z.
Lindberg M, Hu J, Sparr E, Linse S
QRB Discov. 2025; 6:e8.
PMID: 40070848
PMC: 11894405.
DOI: 10.1017/qrd.2024.12.
Koulouri A, Zannas A
J Alzheimers Dis Rep. 2025; 8(1):1372-1380.
PMID: 40034348
PMC: 11863733.
DOI: 10.1177/25424823241284227.
Applying machine learning to high-dimensional proteomics datasets for the identification of Alzheimer's disease biomarkers.
Ivarsson Orrelid C, Rosberg O, Weiner S, Johansson F, Gobom J, Zetterberg H
Fluids Barriers CNS. 2025; 22(1):23.
PMID: 40033432
PMC: 11874791.
DOI: 10.1186/s12987-025-00634-z.
Limitations and Applications of Rodent Models in Tauopathy and Synucleinopathy Research.
Szegvari E, Holec S, Woerman A
J Neurochem. 2025; 169(3):e70021.
PMID: 40026260
PMC: 11874209.
DOI: 10.1111/jnc.70021.
Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer's Disease Model.
Ando K, Kosa A, Mehadji Y, Lasri H, Lopez-Gutierrez L, Quintanilla-Sanchez C
Biomolecules. 2025; 15(2).
PMID: 40001463
PMC: 11853399.
DOI: 10.3390/biom15020159.
[Diagnosis and Treatment of Alzheimer's Disease: Current Update].
Yim Y, Moon W
J Korean Soc Radiol. 2025; 86(1):6-16.
PMID: 39958494
PMC: 11822271.
DOI: 10.3348/jksr.2024.0146.
Molecular interactions, structural effects, and binding affinities between silver ions (Ag) and amyloid beta (Aβ) peptides.
Lakela A, Berntsson E, Vosough F, Jarvet J, Paul S, Barth A
Sci Rep. 2025; 15(1):5439.
PMID: 39948350
PMC: 11825922.
DOI: 10.1038/s41598-024-59826-6.
Metabolic Profiling of Brain Tissue and Brain-Derived Extracellular Vesicles in Alzheimer's Disease.
Hernandez P, Rackles E, Alboniga O, Martinez-Lage P, Camacho E, Onaindia A
J Extracell Vesicles. 2025; 14(2):e70043.
PMID: 39901643
PMC: 11791017.
DOI: 10.1002/jev2.70043.
NXP032 Improves Memory Impairment Through Suppression of Tauopathy in PS19 Mice and Attenuates Okadaic Acid-Induced Tauopathy in SH-SY5Y Cells.
Eo H, Kim S, Ju I, Lee J, Oh M, Kim Y
J Neuroimmune Pharmacol. 2025; 20(1):10.
PMID: 39891801
DOI: 10.1007/s11481-025-10175-9.
A 3D-induced pluripotent stem cell-derived human neural culture model to study certain molecular and biochemical aspects of Alzheimer's disease.
Prasannan P, Siney E, Chatterjee S, Johnston D, Shah M, Mudher A
In Vitro Model. 2025; 1(6):447-462.
PMID: 39872613
PMC: 11756488.
DOI: 10.1007/s44164-022-00038-5.
Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications.
He S, Xu Z, Han X
Mol Neurodegener. 2025; 20(1):11.
PMID: 39871348
PMC: 11773937.
DOI: 10.1186/s13024-025-00803-6.
An approach to predict and inhibit Amyloid Beta dimerization pattern in Alzheimer's disease.
Roy S, Biswas S, Nandy A, Guha D, Dasgupta R, Bagchi A
Toxicol Rep. 2025; 14:101879.
PMID: 39867516
PMC: 11762949.
DOI: 10.1016/j.toxrep.2024.101879.
Molecular Mechanisms of Alzheimer's Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy.
Ahn E, Park J
Cells. 2025; 14(2).
PMID: 39851517
PMC: 11764136.
DOI: 10.3390/cells14020089.
Disruption in Sleep and Circadian Rhythm: A Potential Accelerator in Alzheimer's Disease Progression.
Khan A, Abdullah A, Mustafa M, Qadeer M
Ann Neurosci. 2025; 31(4):246-249.
PMID: 39840145
PMC: 11744612.
DOI: 10.1177/09727531231200958.
Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review.
De Cleene N, Schwarzova K, Labrecque S, Cerejo C, Djamshidian A, Seppi K
Front Neurosci. 2025; 18():1505029.
PMID: 39840019
PMC: 11747286.
DOI: 10.3389/fnins.2024.1505029.
Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer's disease, and late-onset Alzheimer's disease.
Marta-Ariza M, Leitner D, Kanshin E, Suazo J, Giusti Pedrosa A, Thierry M
Acta Neuropathol. 2025; 149(1):9.
PMID: 39825890
PMC: 11742868.
DOI: 10.1007/s00401-025-02844-z.
Peripheral proteinopathy in neurodegenerative diseases.
Xu B, Lei X, Yang Y, Yu J, Chen J, Xu Z
Transl Neurodegener. 2025; 14(1):2.
PMID: 39819742
PMC: 11737199.
DOI: 10.1186/s40035-024-00461-6.